[144] BKV Corp SEC Filing

Rhea-AI Filing Summary

BKV Corp (BKV) affiliate filed a Form 144 to sell up to 21,719 common shares through Charles Schwab, with an aggregate market value of $608,201.00. The filing lists an approximate sale date of November 14, 2025 on the NYSE.

The shares were acquired on August 22, 2024 via restricted stock lapse as equity compensation. BKV had 89,970,076 shares outstanding at the time referenced. Over the past three months, the person reported sales of 100,000 shares on November 10, 2025 for $2,615,856.00 and 100,000 shares on November 11, 2025 for $2,713,138.00.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	21719	608201.00	89970076	11/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2024	Restricted Stock Lapse	BKV Corp			21719	08/22/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher P Kalnin 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	11/10/2025	100000	2615856.00
Christopher P Kalnin 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	11/11/2025	100000	2713138.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BKV’s Form 144 filing disclose?

It notices a planned sale of 21,719 common shares with an aggregate market value of $608,201.00 on the NYSE.

When are the BKV shares expected to be sold?

The filing lists an approximate sale date of November 14, 2025.

How were the BKV shares acquired by the seller?

They were acquired on August 22, 2024 via restricted stock lapse as equity compensation.

How many BKV shares are outstanding as context?

Shares outstanding were 89,970,076 at the referenced time.

Which broker and exchange are listed for the sale?

Broker: Charles Schwab & Co., Inc.; Exchange: NYSE.

Were there recent BKV share sales by the same person?

Yes. 100,000 shares sold on Nov 10, 2025 for $2,615,856.00 and 100,000 on Nov 11, 2025 for $2,713,138.00.